Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Pioglitazone for the Prevention of Radiation-Induced Cognitive Dysfunction

NCT01151670 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.

NCT NCT01151670
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01151670 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Pioglitazone for the Prevention of Radiation-Induced Cognitive Dysfunction
Lead sponsor
Wake Forest University Health Sciences
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2010
Completion date
August 31, 2014
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic astrocytoma, brain neoplasms, benign, brain neoplasms, malignant, glioblastoma multiforme, malignant meningioma